Ceftazidime is a potential drug to inhibit SARS-CoV-2 infection in vitro by blocking spike protein–ACE2 interaction

Detalles Bibliográficos
Autores principales: Lin, ChangDong, Li, Yue, Zhang, YueBin, Liu, ZhaoYuan, Mu, Xia, Gu, Chenjian, Liu, Jing, Li, Yutang, Li, GuoHui, Chen, JianFeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129692/
https://www.ncbi.nlm.nih.gov/pubmed/34006835
http://dx.doi.org/10.1038/s41392-021-00619-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129692/
https://www.ncbi.nlm.nih.gov/pubmed/34006835
http://dx.doi.org/10.1038/s41392-021-00619-y

Ejemplares similares